Characterization of cultured insect cells selected by Bacillus thuringiensis crystal toxin

被引:14
|
作者
Liu, KY [1 ]
Zheng, BL [1 ]
Hong, HZ [1 ]
Jiang, CF [1 ]
Peng, R [1 ]
Peng, JX [1 ]
Yu, ZH [1 ]
Zheng, J [1 ]
Yang, H [1 ]
机构
[1] Cent China Normal Univ, Inst Entomol, Wuhan 430079, Peoples R China
关键词
Trichoplusia ni cell line TnH5; Bacillus thuringiensis; resistance; glycosylation; N-acetylgalactosamine; proteome;
D O I
10.1290/0404032.1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Selection for resistance against Bacillus thuringiensis (Bt) Cry1Ac10 in the Trichoplusia ni (Hubner) Cell line BTI-TN5-B1-4 (TnH5) was tested, and the development of resistance in the selected cells was like a S-form curve. Monitoring at the Cry1Ac10 50th challenge, the resistance ratio was 1, 294-fold as many as that of initial cells. But the resistance to Cry1Ac10 declined gradually when the selection was relaxed. The resistance declined rapidly at the low level of resistance and slowly at the high level of resistance. This resistant cell had high resistance to all the tested solubilized trypsin-treated mixture of crystal multitoxins of B. thuringiensis subsp. aizawai GC-91, an engineering bacterium of Bt, B. thuringiensis subsp. aizawai HD-133 and B. thuringiensis subsp. kurstaki HD-1, and low cross-resistance (19.7-fold) to activated Cry1C. Both N-acetyl-D-galactosamine (GalNAc) and tunicamycin did not inhibit the toxicity of Cry1Ac10 to the susceptible TnH5 cells. Comparison of the total proteins of the selected resistant cells with that of the nonselected susceptible cells by two-dimensional electrophoresis analysis showed that were obvious differences among the 11 protein expressions. These results strongly suggest that there exists an unknown mechanism of resistance in the cell line that was different from the reported mechanisms in insects.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 50 条
  • [31] An improved baculovirus insecticide producing occlusion bodies that contain Bacillus thuringiensis insect toxin
    Chang, JH
    Choi, JY
    Jin, BR
    Roh, JY
    Olszewski, JA
    Seo, SJ
    O'Reilly, DR
    Je, YH
    JOURNAL OF INVERTEBRATE PATHOLOGY, 2003, 84 (01) : 30 - 37
  • [32] DELINEATION OF THE TOXIN CODING FRAGMENTS AND AN INSECT-SPECIFICITY REGION OF A DUAL TOXICITY BACILLUS-THURINGIENSIS CRYSTAL PROTEIN GENE
    HAIDER, MZ
    SMITH, GP
    ELLAR, DJ
    FEMS MICROBIOLOGY LETTERS, 1989, 58 (2-3) : 157 - 163
  • [33] Purification and characterization of Bacillus thuringiensis vegetative insecticidal toxin protein(s)
    Osman, G.
    Assaeedi, A.
    Osman, Y.
    El-Ghareeb, D.
    Alreedy, R.
    LETTERS IN APPLIED MICROBIOLOGY, 2013, 57 (04) : 310 - 316
  • [34] BIOCHEMISTRY AND GENETICS OF INSECT RESISTANCE TO BACILLUS-THURINGIENSIS INSECTICIDAL CRYSTAL PROTEINS
    FERRE, J
    ESCRICHE, B
    BEL, Y
    VANRIE, J
    FEMS MICROBIOLOGY LETTERS, 1995, 132 (1-2) : 1 - 7
  • [35] SEMIAUTOMATED QUANTIFICATION OF CYTOTOXIC DAMAGE-INDUCED IN CULTURED INSECT CELLS EXPOSED TO COMMERCIAL BACILLUS-THURINGIENSIS BIOPESTICIDES
    TAYABALI, AF
    SELIGY, VL
    JOURNAL OF APPLIED TOXICOLOGY, 1995, 15 (05) : 365 - 373
  • [36] Toxicity and binding properties of the Bacillus thuringiensis delta-endotoxin Cry1C to cultured insect cells
    Kwa, MSG
    de Maagd, RA
    Stiekema, WJ
    Vlak, JM
    Bosch, D
    JOURNAL OF INVERTEBRATE PATHOLOGY, 1998, 71 (02) : 121 - 127
  • [37] MYOTOXIC AND NEUROTOXIC ACTIVITY OF BACILLUS-THURINGIENSIS VAR ISRAELENSIS CRYSTAL TOXIN
    SINGH, GJP
    GILL, SS
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1985, 24 (03) : 406 - 414
  • [39] Characterisation of the Binding Properties of Bacillus Thuringiensis 18 Toxin on Leukaemic Cells
    Wong, Rebecca S. Y.
    Mohamed, Shar M.
    Nadarajah, Vishna D.
    Tengku, Ibrahim Azmi T.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [40] Characterisation of the Binding Properties of Bacillus Thuringiensis 18 Toxin on Leukaemic Cells
    Rebecca SY Wong
    Shar M Mohamed
    Vishna D Nadarajah
    Ibrahim Azmi T Tengku
    Journal of Experimental & Clinical Cancer Research, 29